Antioxidant enzyme polymorphisms and neuropsychological outcomes in medulloblastoma survivors: a report from the Childhood Cancer Survivor Study

Neuro Oncol. 2012 Aug;14(8):1018-25. doi: 10.1093/neuonc/nos123. Epub 2012 Jun 1.

Abstract

Psychological or neurocognitive impairment is often seen in medulloblastoma survivors after craniospinal radiation; however, significant variability in outcomes exists. This study investigated the role of antioxidant enzyme polymorphisms in moderating this outcome and hypothesized that patients who had polymorphisms associated with lower antioxidant enzyme function would have a higher occurrence of impairment. From the Childhood Cancer Survivor Study (CCSS) cohort, 109 medulloblastoma survivors and 143 siblings were identified who completed the CCSS Neurocognitive Questionnaire (NCQ) and the Brief Symptom Inventory-18 (BSI-18) and who provided buccal DNA samples. Real-time polymerase chain reaction (PCR) allelic discrimination was used for SOD2 (rs4880), GPX1 (rs1050450), and GSTP1 (rs1695 and rs1138272) genotyping and PCR for GSTM1 and GSTT1 gene deletions. Outcomes on NCQ and BSI-18 subscale scores were examined in association with genotypes and clinical factors, including age at diagnosis, sex, and radiation dose, using univariate and multivariate analysis of variance. Patients <7 years of age at diagnosis displayed more problems with task efficiency (P < .001) and fewer problems with somatic complaints (P = .004) than did patients ≥7 years of age. Female patients reported more organization problems than did male patients (P = .02). Patients with homozygous GSTM1 gene deletion reported higher anxiety (mean null genotype = 47.3 ± 9.2, non-null = 43.9 ± 7.8; P = .04), more depression (null = 51.0 ± 9.8, non-null = 47.0 ± 9.4; P = .03), and more global distress (null = 50.2 ± 9.7, non-null = 45.2 ± 9.9; P = .01). All associations for the GSTM1 polymorphism remained statistically significant in a multivariate model controlling for age, sex, and radiation dose. Homozygous GSTM1 gene deletion was consistently associated with greater psychological distress in medulloblastoma survivors across multiple domains, suggesting that this genotype may predispose patients for increased emotional late effects.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antioxidants*
  • Cerebellar Neoplasms / psychology
  • Cerebellar Neoplasms / radiotherapy*
  • Child
  • Cranial Irradiation / adverse effects*
  • Female
  • Genetic Predisposition to Disease / genetics*
  • Genotype
  • Glutathione Peroxidase / genetics
  • Glutathione Peroxidase GPX1
  • Glutathione Transferase / genetics
  • Humans
  • Male
  • Medulloblastoma / psychology
  • Medulloblastoma / radiotherapy*
  • Mental Disorders / etiology
  • Mental Disorders / genetics*
  • Middle Aged
  • Multiplex Polymerase Chain Reaction
  • Neuropsychological Tests
  • Polymorphism, Single Nucleotide
  • Real-Time Polymerase Chain Reaction
  • Superoxide Dismutase / genetics
  • Survivors
  • Young Adult

Substances

  • Antioxidants
  • Glutathione Peroxidase
  • Superoxide Dismutase
  • superoxide dismutase 2
  • Glutathione Transferase
  • Glutathione Peroxidase GPX1
  • GPX1 protein, human